Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Coronary Artery Disease and meta-analysis and CYP2C19[original query] |
|---|
| Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis. The pharmacogenomics journal 2011 Jun 11 (3): 199-206. Sofi F, Giusti B, Marcucci R, Gori A M, Abbate R, Gensini G |
| Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ (Clinical research ed.) 2011 343 d4588. Bauer Tim, Bouman Heleen J, van Werkum Jochem W, Ford Neville F, ten Berg Jurriën M, Taubert Di |
| Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel. Heart (British Cardiac Society) 2011 Jun . Zabalza M, Subirana I, Sala J, Lluis-Ganella C, Lucas G, Tomás M, Masiá R, Marrugat J, Brugada R, Elosua R |
| The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients. Journal of thrombosis and haemostasis : JTH 2011 Nov . Li Y, Tang HL, Hu YF, Xie HG |
| Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel. The American journal of cardiology 2012 Aug 110 (4): 502-8. Jang Jae-Sik, Cho Kyoung-Im, Jin Han-Young, Seo Jeong-Sook, Yang Tae-Hyun, Kim Dae-Kyeong, Kim Dong-Soo, Seol Sang-Hoon, Kim Doo-Il, Kim Bo-Hyun, Park Yong Hyun, Je Hyung-Gon, Jeong Young-Hoon, Lee Seung-Wh |
| Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Archives of cardiovascular diseases 2013 Oct 106 (10): 517-27. Mao Liu, Jian Chen, Changzhi Liu, Dan Huang, Suihua Huang, Wenyi Tang, Wei |
| CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2015 Apr 35 (2): 147-56. Niu Xuan, Mao Ling, Huang Yan, Baral Suraj, Li Jian-yong, Gao Yuan, Xia Yuan-peng, He Quan-wei, Wang Meng-die, Li Man, Zou Li, Miao Xiao-ping, Hu |
| Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2017 22 109. Huang Bo, Cui De-Jun, Ren Ying, Han Bin, Yang Da-Ping, Zhao X |
| CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2018 11 93 (7): 1246-1252. Kheiri Babikir, Osman Mohammed, Abdalla Ahmed, Haykal Tarek, Pandrangi Pranay V, Chahine Adam, Ahmed Sahar, Osman Khansa, Bachuwa Ghassan, Hassan Mustafa, Bhatt Deepak |
| Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis. European journal of internal medicine 2021 Jun . Jafrin Sarah, Naznin Nura Ershad, Reza Md Sharif, Aziz Md Abdul, Islam Mohammad Safiq |
| Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
| Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis. Cardiovascular drugs and therapy 2021 2 35 (6): 1147-1159. Biswas Mohitosh, Kali Sumaiya Khat |
| Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Drugs 2024 9 . Dominique P M S M Maas, Loes H Willems, Josephine Kranendonk, Cornelis Kramers, Michiel C War |
| Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach. International journal of cardiology 2024 8 414 132418. Ruchika Sharma, Geeta Aggarwal, Anoop Kumar, Ajit K Thakur, Mahak Pandit, Varun Sharma, Manmohan Singh, Jaseela Majeed, Puneeta Ajme |
- Page last reviewed:Feb 1, 2024
- Content source: